Skip to content

Insider · CIK 0002094484

BCP 8 Holdings Mozart Manager L.L.C.

owner

Files at MDLN (Medline Inc.). First filing Mar 12, 2026, latest Jun 1, 2026.

BCP 8 Holdings Mozart Manager L.L.C. files SEC Form 4 as 10% owner at MDLN (Medline Inc.). Since Mar 12, 2026, BCP 8 Holdings Mozart Manager L.L.C. has reported 0 open-market buys worth $0 and 2 open-market sells worth $2.3B, the latest filed on Jun 1, 2026.

A track record needs three past buys with six months of prices behind them; BCP 8 Holdings Mozart Manager L.L.C. has 0, so none is measured yet.

The newest scored trade: sold $1.2B of MDLN on May 28, 2026, filed Jun 1, 2026, scored 62 (notable). In the last 12 months: 0 buys worth $0 and 2 sells worth $2.3B.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $2.3B sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

MDLN: Medline Inc.

MDLNOct 9, 2026 · close 36.26

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
62Notable
MDLNsell 3
Medline Inc.
$1.2B
33,317,824 shares
-30%+3% from low-26% from high
57Moderate
MDLNsell 7
Medline Inc.
$1.1B
27,852,986 shares
-22%+10% from low-14% from high

Transactions

Every row this insider has filed, 28 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
May 28, 2026MDLN
Medline Inc.
SOpen-market sale
Class A Common Stockindirect: See Footnotes
-19,712,326$36.54$720M89,537,913Jun 1, 2026
May 28, 2026MDLN
Medline Inc.
SOpen-market sale
Class A Common Stockindirect: See Footnotes
-9,858,774$36.54$360M10,185Jun 1, 2026
May 28, 2026MDLN
Medline Inc.
SOpen-market sale
Class A Common Stockindirect: See Footnotes
-2,256,800$36.54$82M10,250,904Jun 1, 2026
May 28, 2026MDLN
Medline Inc.
SOpen-market sale
Class A Common Stockindirect: See Footnotes
-1,489,924$36.54$54M1,539Jun 1, 2026
May 28, 2026MDLN
Medline Inc.
JOther
Class A Common Stockindirect: See Footnotes
-438,214--1,990,467Jun 1, 2026
May 21, 2026MDLN
Medline Inc.
CConversion
Class A Common Stockindirect: See Footnotes
+9,858,774--9,868,959May 26, 2026
May 21, 2026MDLN
Medline Inc.
CConversion
Class A Common Stockindirect: See Footnotes
+1,489,924--1,491,463May 26, 2026
May 21, 2026MDLN
Medline Inc.
JOther
Class B Common Stockindirect: See Footnotes
-9,858,774--44,770,628May 26, 2026
May 21, 2026MDLN
Medline Inc.
JOther
Class B Common Stockindirect: See Footnotes
-1,489,924--6,766,039May 26, 2026
May 21, 2026MDLN
Medline Inc.
CConversion
Common Units of Medline Holdings, LPderivativeindirect: See Footnotes
-9,858,774$0.00$044,770,628May 26, 2026
May 21, 2026MDLN
Medline Inc.
CConversion
Common Units of Medline Holdings, LPderivativeindirect: See Footnotes
-1,489,924$0.00$06,766,039May 26, 2026
Mar 10, 2026MDLN
Medline Inc.
SOpen-market sale
Class A Common Stockindirect: See Footnotes
-16,479,083$40.51$668M109,250,239Mar 12, 2026
Mar 10, 2026MDLN
Medline Inc.
SOpen-market sale
Class A Common Stockindirect: See Footnotes
-8,241,723$40.51$334M10,185Mar 12, 2026
Mar 10, 2026MDLN
Medline Inc.
SOpen-market sale
Class A Common Stockindirect: See Footnotes
-1,886,636$40.51$76M12,507,704Mar 12, 2026
Mar 10, 2026MDLN
Medline Inc.
SOpen-market sale
Class A Common Stockindirect: See Footnotes
-1,245,544$40.51$50M1,539Mar 12, 2026
Mar 10, 2026MDLN
Medline Inc.
JOther
Class A Common Stockindirect: See Footnotes
-366,337--2,428,681Mar 12, 2026
Mar 4, 2026MDLN
Medline Inc.
CConversion
Class A Common Stockindirect: See Footnotes
+7,166,716--7,176,901Mar 6, 2026
Mar 4, 2026MDLN
Medline Inc.
CConversion
Class A Common Stockindirect: See Footnotes
+1,083,082--1,084,621Mar 6, 2026
Mar 4, 2026MDLN
Medline Inc.
JOther
Class B Common Stockindirect: See Footnotes
-7,166,716--55,704,409Mar 6, 2026
Mar 4, 2026MDLN
Medline Inc.
JOther
Class B Common Stockindirect: See Footnotes
-1,083,082--8,418,425Mar 6, 2026
Mar 5, 2026MDLN
Medline Inc.
CConversion
Class A Common Stockindirect: See Footnotes
+1,075,007--8,251,908Mar 6, 2026
Mar 5, 2026MDLN
Medline Inc.
CConversion
Class A Common Stockindirect: See Footnotes
+162,462--1,247,083Mar 6, 2026
Mar 5, 2026MDLN
Medline Inc.
JOther
Class B Common Stockindirect: See Footnotes
-1,075,007--54,629,402Mar 6, 2026
Mar 5, 2026MDLN
Medline Inc.
JOther
Class B Common Stockindirect: See Footnotes
-162,462--8,255,963Mar 6, 2026
Mar 4, 2026MDLN
Medline Inc.
CConversion
Common Units of Medline Holdings, LPderivativeindirect: See Footnotes
-7,166,716$0.00$055,704,409Mar 6, 2026
Mar 4, 2026MDLN
Medline Inc.
CConversion
Common Units of Medline Holdings, LPderivativeindirect: See Footnotes
-1,083,082$0.00$08,418,425Mar 6, 2026
Mar 5, 2026MDLN
Medline Inc.
CConversion
Common Units of Medline Holdings, LPderivativeindirect: See Footnotes
-1,075,007$0.00$054,629,402Mar 6, 2026
Mar 5, 2026MDLN
Medline Inc.
CConversion
Common Units of Medline Holdings, LPderivativeindirect: See Footnotes
-162,462$0.00$08,255,963Mar 6, 2026

Questions about BCP 8 Holdings Mozart Manager L.L.C.

Answered from the filings on this page, as of the latest one.

Is BCP 8 Holdings Mozart Manager L.L.C. buying or selling?

In the last 12 months BCP 8 Holdings Mozart Manager L.L.C. reported 0 open-market buys worth $0 and 2 open-market sells worth $2.3B on SEC Form 4; the latest was sold $1.2B of MDLN on May 28, 2026. Grants, option exercises and tax withholding are not counted.

How did BCP 8 Holdings Mozart Manager L.L.C.'s past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and BCP 8 Holdings Mozart Manager L.L.C. has 0.

Where does BCP 8 Holdings Mozart Manager L.L.C. file Form 4?

BCP 8 Holdings Mozart Manager L.L.C. has filed Form 4 at MDLN (Medline Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.